Ian T. Clark

Ian T. Clark has served as a member of our board of directors since July 2024. Mr. Clark is an advisor to KKR & Co. Inc., a global investment firm. Mr. Clark formerly served as Chief Executive Officer, led the executive committee, and was a member of the board of directors of Genentech, Inc., a biotechnology company, from January 2010 until his retirement in December 2016. In total, he served for 14 years at Genentech, Inc. Before that, Mr. Clark served as Senior Vice President and General Manager of BioOncology. Prior to this, Mr. Clark spent 20 years in positions of increasing responsibility at Novartis International AG, Sanofi S.A., Ivax Pharmaceuticals, Inc. and G.D. Searle, LLC. Currently, Mr. Clark is on the board of directors of several public biopharmaceutical and biotechnology companies: Kyverna Therapeutics, Inc., Olema Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, Guardant Health, Inc. and Corvus Pharmaceuticals, Inc. Mr. Clark received his B.S. in Biological Sciences and an Honorary Doctorate of Science from Southampton University. We believe Mr. Clark is qualified to serve on our Board of Directors because of his extensive experience and expertise in the pharmaceutical and healthcare industries gained as an executive and director of multiple publicly traded and private companies operating in those industries.

site - Investor Tools